Effect of lysolecithin on the oxygen uptake of tumour cells, polymorphonuclear leucocytes, lymphocytes and macrophages in vitro. by Butterworth, A. E. & Cater, D. B.
373
EFFECT OF LYSOLECITHIN ON THE OXYGEN UPTAKE OF
TUMOUR CELLS, POLYMORPHONUCLEAR LEUCOCYTES,
LYMPHOCYTES AND MACROPHAGES IN VITRO
A. E. BUTTERWORTH AND D. B. CATER*
From the Department ofPathology, University of Cambridge
Received for publication November 25, 1966
LYSOLECITHN has been widely studied as a surface-active haemolytic agent
(Robinson, 1961) and has been implicated in immune haemolysis (Fischer, 1964),
in hypersensitivity reactions (Middleton and Phillips, 1963, 1964), and in the
delayed stage of the increase of vascular permeability in inflammation (Cotran
and Majno, 1964).
Fischer (1964) found that the oxygen uptake (Q02) oftumour cells was reduced
by small concentrations of "lysolecithin", whilemicro andmacrophages responded
by an increase Of Q02 and phagocytic activity. We felt that this observation
should be confirmed, because it could form the basis of a therapeutic method of
increasing the radiosensitivity of tumours by raising the oxygen tension (PO2),
and from the theoretical aspect might clarify differences between the cell mem-
branes of tumour and of normal cells. Moreover, Fischer's experiments are open
to criticism. His cell suspension was stirred by a moving mercury seal and this
could have produced cell damage from mercury poisoning. Also he treated his
cell suspensions not with lysolecithin, but with complement plus a specific anti-
body against cell antigen, and assumed, from previous work, that these would
liberate lysolecithin at the cell surface. Phillips and Middleton (1965), however,
could not demonstrate the production of-lysolecithin in an immune haemolytic
system. Fischer used Munder's modification of the Clark oxygen cathode to
record changes of P02 in his cell suspension; in the present work we used mem-
brane covered electrodes (Silver, 1963) which have a greater sensitivity and a
much faster response-time than the Clark electrode (1-3 sec. for 95% response).
Our aims were -
(a) to find a reproducible method for comparing the oxygen uptake of treated
and control cells;
(b) to examine the concentration of lysolecithin that would affect the oxygen
uptake of ascites tumour cells; and
(c) to test the effect of such a concentration on polymorphonuclear leucocytes,
lymphocytes and macrophages.
METHODS
Solutions
All vessels, pipettes, etc. used in preparing cell suspensions were of siliconed
glassware or non-wettable plastic. Cell suspensions were diluted with tris-
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citrate buffered Hanks' balanced salt solution (Hanks, 1948), pH 6-9 to 7-2,
containing heparin, 3 mg.% w/v, and streptomycin 100 I.U./ml. (abbreviated to
Hanks' H soln.)
Lysolecithin (Koch-Light Lab. " pure lysolecithin, batch 18994 ", and " pure
lysolecithin (ex egg lecithin, crystallized, batch 25436 ") was prepared by grinding
with Ringer phosphate pH 7 0-7 3 in a mortar for 5 min. after the method of
Dawson, Mann and White (1957). The slightly opaque, " soapy " suspension
(1.5-2.0 mg. lysolecithin/ml.) was used within 2 hours of preparation. In pilot
experiments, when lysolecithin was merely shaken with Ringer phosphate, little
effect on the oxygen uptake of cells was observed. The lysolecithin in such cases
may have formed a surface film.
Technique of measurement of the oxygen tension (PO2) in cell suspensions
The oxygen-cathode (Silver, 1963) was inserted into a siliconed glass cuvette
containing a stirrer and 1 0-1 3 ml. of cell suspension, as shown in Fig. 1. (A
layer of cell-suspension above the constriction of the cuvette formed a buffer of
cells and prevented oxygenleakingfrom the airthrough imperfections ofelectrode/
cuvette fit). Two such cuvettes with electrodes were immersed in a small water
bath placed on top of a magnetic stirrer which rotated the stirrerrods (iron wire in
siliconed glass) in both cuvettes. The small water bath was kept at constant
temperature by a flow of water at 5 ml./sec. from a large thermostatically con-
trolled water bath. Each electrode was connected to a polarizing voltage of
0-6 V. and an amplifier, as described by Cater, Silver and Wilson (1959).
Calibration.-The electrode gives a small current in N2, but when this is
subtracted the p02/current response is linear. N2 currents were determined by
passing N2 via a copper tube through a stainless steel cuvette with which the
electrode made a gas-tight fit. Water equilibrated with air at 370 C. was used to
calibrate the electrodes. The absolute value was only important in calculating
absolute oxygen uptake, not in comparing treated and untreated cells. Calibra-
tion of electrodes was checked before each experiment.
Experimental procedure.-A known volume of well-mixed cell suspension was
added to each cuvette and allowed to reach 370 C. Suspensions were oxygenated
either directly or by adding a known volume ofoxygenated Hanks' H soln. to the
cuvette, with calculation ofthe new number ofcells/ml. The electrodes were then
fitted and readings taken at 0 5-3 minute intervals. The zero drift of each
amplifier was corrected every 3 minutes. Then lysolecithin soln. was added to
one cuvette and well mixed with the cells in a Pasteur pipette. An equal volume
ofRinger phosphate was added to the other cuvette which acted as a control.
Preparation of cell suspensions
(1) BP8 ascites tumour cells.-1 x 105 BP8 ascites tumour cells were injected
i.p. into C3H mice and harvested 10-15 days later. The mice were killed and
1.5 ml. Hanks' H soln. injected i.p. to prevent coagulation of the cells. The
abdomen was then opened and the ascitic fluid withdrawn with a siliconed pipette.
Ascitic fluid grossly contaminated with blood was discarded. Cell counts were
made and the fluid diluted with Hanks' H soln. when necessary. Up to 5 X 108
tumour cells could be obtained from one mouse; the final suspensions contained
>95% tumour cells.
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(2) Rat hepatoma.-Transplantable hepatoma 223 passaged as an ascites
tumour in August strain rats grows mainly as multiple solid nodules in the
omentum and mesentery. The ascitic fluid was very bloody and was discarded.
Tumour nodules were minced with scissors in a sterile plastic Petri dish with
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FIG. 1.-Diagram ofapparatus showing the oxygen electrode inserted into the vessel (cuvette)
containing the cell suspension and a magnetic stirrer. The inset shows the structure of the
electrode in detail.
Hanks' H soln. and pressed twice through double layers of muslin into sterile,
siliconed glass vessels. The final suspension contained about 5 X 107 cells/ml.,
> 90% tumour cells.
(3) Polymorphonruclear leucocyte8.-The method of Cohn and Morse (1960)
was used-05 ml. of 0.1% oyster glycogen (BDH) in sterile Ringer phosphate
was injected at 40-45° C. i.p. into each of 5-9 Tuck No. 1 mice. The mice were
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killed 4-5 hr. later; 1-5 ml. Hanks' H soln. was injected i.p., distributed by gently
tapping the abdomen, and then removed. The cell suspension was centrifuged
in siliconed tubes at 150 g for 3 min. and resuspended in Hanks' H soln. to give a
final volume of3-5 ml. anda cell count of3-5 x 107 cells/ml., 80-90% polymorphs,
with mononuclear cells as the main contaminants.
(4) Lymphocytes.-For each experiment 4 Tuck No. 1 mice were killed. Their
inguinal, axillary and subscapular lymph nodes were dissected free of fat, minced
in Hanks' H soln. and strained through muslin as for rat hepatoma to give a final
suspension of 2-5 X 107 cells/ml., 80-90% lymphocytes, with mononuclear and
fat cells as the main contaminants.
(5) Macrophages were prepared by a modification of the methods of Nelson
and Becker (1959) and ofBerk, Nelson and Pickett (1960). In early experiments
0.3 ml. liquid paraffin at 400 to 450 C. was injected i.p. into each of 11, female
Tuck No. 1 mice, which were killed 18 hours later. The cells were harvested,
centrifuged and resuspended as described above under polymorphonuclear leuco-
cytes. The final suspension contained about 4 X 107 cells/ml., of which > 90%
were macrophages. Since there was some residual paraffin in the suspension, in
later experiments 1 ml. of 0 1% glycogen was injected instead, and the cells were
harvested at 24-48 hours.
RESULTS
The current readings (after subtracting the N2 current) were converted to %
atmospheric P02 and graphs were plotted of the % change against time. The
change/min./107 viable cells, read from the straight line portion of the plot, was
called Vmax-the characteristic oxygen uptake of that particular suspension of
cells. 1 ml. of water equilibrated with air at 370 C. contains dissolved oxygen
which would occupy 4-27 jd. at NTP. Therefore a 1% change of p02/min. equals
0-1262 lamoles 02 uptake/hr. (The estimate would be slightly inaccurate if there
was much protein in the solution; Cater, Silver and Wilson (1959) found that the
addition of 2.5% protein reduced the amount of oxygen in solution at constant
P02 by 3%). The Q02 can be expressed in terms either of viable cells or of mg.
dry weight. (Estimations of dry weight were made for BP8 cells by weighing a
known volume of washed cell suspension left overnight at 60° C., in a weighed
watch-glass. The cell count was known and corrections were made for the dry
weight of the salts in the suspending medium). If, after the addition of lysole-
cithin, the rate of oxygen uptake became less this was expressed as
p g i o = (Vmax - Vmax post-lysolecithin) x 100 percentage inhibition = Vmax
Due allowance was made, in calculating Vmax, for a reduction (if any) in the rate
of oxygen uptake by the control suspension with time.
BP8 Ascites tumour cells
Normal oxygen uptake.-For all BP8 tumours harvested between 10-12 days
after i.p. injection the rate of oxygen uptake was directly proportional to the
number of cells, over the range from 6-60 x 106 cells./ml. (Fig. 2). A mean
value of 9.3% change of P02/107 viable cells/min., or a Q02 of 117 4umoles 02/107
viable cells/hr. was found. Older tumours showed lower rates of oxygen uptake/
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cell; thus tumours harvested at 13-14 days showed 6% change of P02/107
cells/min., and those harvested in the 15th day about 4%. Few experiments
were therefore made with the older tumours.
Lysolecithin-treated BP8 cells. Lysolecithin reduced the rate ofoxygen uptake
of the cells. A typical experiment is shown in Fig. 3 where 62% inhibition was
produced by 9.8 uzg. lysolecithin/106 cells. Note that the oxygen uptake after
treatment, although diminished, remained constant. This suggested that the
lysolecithin became attached to the cells almost immediately and was then no
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FIG. 2.--The rate of oxygen uptake of untreated cell suspensions was proportional to the
number of cells per ml. BP8 ascites tumour cells grown in C3H mice0; mouse lympho-
cytesO.
longer available to other cells. With higher concentrations of lysolecithin in
some experiments the rate of oxygen uptake decreased with time and microscopic
examination then showed dense coagulation of the cells. This coagulation may
have occurred over a period of time and progressively interfered with access of
oxygen to the innermost cells. The Vmax was therefore calculated from the
early part of the curve. From these observations, it was thought likely that
the concentration of lysolecithin/cell, and not the absolute concentration of
lysolecithin, would determined the degree of inhibition of oxygen uptake. A
series ofexperiments was therefore performed with varying concentrations of both
lysolecithin and cells. It was found that % inhibition bore no relationship to
absolute concentration of lysolecithin, but gave a straight line plot with log [dose
of lysolecithin/cell], as shown in Fig. 4. Fifty per cent inhibition occurred with
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6-4 jug. lysolecithin/106 cells (log10 dose = 0-806 i 0.053). No inhibition occur-
red with less than 1 Ftg. lysolecithin/106 cells.
Fig. 5 shows an interesting effect seen at low values oflysolecitin/cell. While
the Vmax was only slightly reduced, the decrease in rate of 02 uptake at low P02
was much less abrupt, and the KmO2 value was raised to 20% atmospheric or
FIG. 3.-Lysolecithin reduced the rate of oxygen uptake of cells. A typical experiment
showing the fall of oxygen tension with time of BP8 cell suspensions before treatment0;
and after treatment with 958 ,ug. lysolecithin/106 cells 0. The inhibition of the rate of
oxygen uptake was 62%.
30 mm. Hg. This effect was not due to agglutination, because no gross agglutina-
tion was seen and re-oxygenation restored the post-lysolecithin Vmax.
As already noted, a reduction of normal 02 uptake/total cells/ml./min.
occurred with increasing age of BP8 tumour. This was due to an increasing %/0
ofdead cells in the tumours harvested on the 13, 14 and 15th day. It was thought
that dead cells might absorb lysolecithin and therefore more lysolecithin would be
needed to produce the same degree of inhibition. Because old tumours were
avoided data on this point are scanty, but 14 day tumours needed a higher dose of
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lysolecithin for 50% inhibition than 11 day tumours, whereas 12-13 day tumours
were more sensitive to the action of lysolecithin. This suggested that cell death
was preceded by a change in membrane properties. A sound basis of comparison
therefore requires measurement of rate of oxygen uptake in terms of viable
cells/ml., and oflysolecithin concentration in terms ofptg./total cells.
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FIG. 4.-The percentage inhibition of the rate of oxygen uptake is proportional tolog,, [dose
of lysolecithin per cell]. For BP8 cells, *, 50% inhibition occurred with 6-4 ,ug. lygo.
lecithin per 106 cells and for rat hepatoma, O, 11-8 gug./10fi total cells.
Micro8copy of Iy8olecithin-treated BP8 ce11s.-4,ug. lysolecithin per 106 cells
inhibited oxvgenuptake by40%/, but as 70%/ ofthe cells were swollen and stained
by Trypan Blue, it appeared that oxygen uptake could occur after increase of cell
permeability. Slight coagulation had occurred. At 20,ug./106 cells, oxygen
uptake was completely inhibited (Fig. 4, loglo 20 = 1-3) but only 20% ofthe cells
stained with Trypan Blue: however, the unstained cells were shrunken, with
jagged cell membranes, highly refractile and with no visible intracellular detail.
The suspension contained many granules and fragments, the products of cell
lysis, and moderate coagulation had occurred.
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Rat transplantable-hepatoma cells
The oxygen-uptake graphs resembled those for BP8 cells. The Q02 was
039 ± 0 073 ,tmoles 02/107 viable cells/hr. The data for lysolecithin inhibition
shown in Fig. 4 gave a straight line plot against log [dose of lysolecithin/cell],
with 50% inhibition at 15.5 /ug./106 viable cells or in terms of total cell count
(25% of the untreated cells stained with Trypan Blue) 11 8 ,tg.. lysolecithin/106
total cells.
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FIG. 5.-The rate of oxygen uptake of BP8 cells was only slightly reduced by a low dose of
lysolecithin (3-3 psg./1O6 cells) as shown by the initial slope of curve B, 0,compared withthe
initial slope of curve A, *; but the apparent KmO2 (oxygen tension at which the rate of
oxygen uptake falls to half maximum, i V max) was raised. For the untreated cells, curve
A, the j V max was about 2.8%, atmospheric P02 and for the treated cells, curve B, about
23%.
Polymorphonuclear leucocytes
Polymorphonuclear leucocytes proved difficult to work with, because untreated
cells showed a marked tendency to coagulate in vitro, and this sometimes caused
an apparent decrease of oxygen uptake with time, as seen in Fig. 6, curve A. No
strict relation between cell count and oxygen uptake was found for cells from
different batches of mice. Most batches gave about 2% change of P02/107
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cells/min.-a Q02 of 0-31 ,ttmoles 02/10' cells/hr.-but some widely divergent
figures were found, ranging from 0.1 to 0 95 #tmoles 02/107 cells/hr.
With lysolecithin, the rate of oxygen uptake showed a characteristic pro-
gressive decrease (Fig. 6, curve B): therefore values for % inhibition were read
from the gradient of the curve immediately after addition of the drug. A linear
relationship between % inhibition and log [dose oflysolecithin/106 cells] wasagain
found (Fig. 7); lysolecithin 8.4 4,g./106 cells caused 50% inhibition. There was
no inhibition with less than 2 ,ug./106 cells.
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FIG. 6.-A typical experiment with mouse polymorphonuclear leucocytes showing an apparent
decrease ofthe rate ofoxygenuptake with time because of cell aggregation in vitro. Values
for calculation of the percentage inhibition were therefore read from the gradient of the
curves as soon as they had stabilised after the addition oflysolecithin. Curve A, *, normal
oxygen uptake. Curve B, 0, lysolecithin inhibition.
Microscopically lysolecithin-treated cells showed a characteristic agglutination
pattern into a coiled thread of cells. This would be distinguished from the
coagulation which sometimes occurred in control suspension as in these fewer cells
were involved and were clumped into rounded masses. Trypan Blue stained the
outer cells of the spiral agglutinations of treated polymorphs. This coagulation
was probably responsible for the progressive decrease of Q02 with time.
Lymphocytes
Normal oxygen uptake.-Lymphocytes had a constant rate of oxygen uptake
down to a PO2 Of 1-4 mm. Hg., when a sharp change occurred. No cell death
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occurred on leaving the cells for some hours at 370 C., but direct oxygenation by
bubbling appeared to damage the cells. Oxygen uptake was proportional to
viable cell count over a range of 15-60 x 106 cells/ml. (see Fig. 2) and the mean
value was 0-26 /umoles O2/107 viable cells/hr.
Lysolecithin-treated lymphocytes. The experiments with BP8 cells had sug-
gested that lysolecithin became irreversibly attached to cells whether living or
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FiG. 7.-The percentage inhibition of the rate of oxygen uptake is proportional to loglo [dose
of lysolecithin per cell]. The 50% inhibition dose for mouse lymphocytes* is 4 5 ,ug. lysolecithin per lOff cells, and for mouse polymorphonuclear leucocytes (:) 8-4 Pug./106 cells.
dead. Because of the method of preparation, the lymphocyte suspension con-
tained a considerableproportion of deadlymphocytes; therefore it was considered
justifiable to calculate the oxygen uptake in terms of viable cell count, but the
dose of lysolecithin in terms of total cell count. The effect of lysolecithin on
lymphocytes was qualitatively similar to that on BP8 cells. The inhibition was
very rapid and no further decrease of oxygen upta-ke occurred with time. The
plots for lymphocytes were similar to those illustrated in Fig. 3 for BP8 cells and
Fig. 8 for macrophages- all of which are in sharp contrast to those for polymor-
phonuclear leucocytes (Fig. 6). A linear relationship was again found between %/
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inhibition and log [dose of lysolecithin /106 cells] as shown in Fig. 7. Lysoleci-
thin 4-5/tg./l06 total cells/ml. gave 50% inhibition (log10 45 = 0-648 ± 0.030).
Concentrations of lysolecithin less than 1 #g./106 total cells/ml. caused no inhibi-
tion; in fact in two cases such doses increased oxygen uptake by 6 and 10%.
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FIG. 8.-A typical experiment showing the fall of oxygen tension with time of cell suspen-
sions ofmouse macrophages, untreated cells 0, and after treatment with 4-8 pg. lysolecithin
per 106 cells, 0.
Macrophayes
The oxygen uptake of the normal cells was variable; Q02= 0-14-0-44 with a
mean of 0-27 ± 0*028/tmoles O2/107 viable cells/hr. Oxygen bubbling damaged
the cells. After treatment with lysolecithin the rate of oxygen uptake was con-
stant but reduced. Fig. 8 illustrates a typical experiment. The percentage
reduction gave a straight line plot against log [dose of lysolecithin/106 total
cells/ml], as shown in Fig. 9. Lysolecithin 4*24 ,tg./106total cells/ml. gave a
50% reduction (log1o 4-24 = 0-628 ± 0.029). Microscopic examination of macro-
phages treated with 4-8lug. lysolecithin/106 cells/ml., which caused 64% inhibition
ofrate ofoxygen uptake, showed 90% ofthe cells with diffusenuclearstaining with
Trypan Blue. The cells were swollen, contained refractile granules and had an
increased cytoplasmic volume. The cell outlines were roughened or bulbous.
Some debris indicated that cell lysis had occurred. With lysolecithin 10-4 ,ug./106
cells/ml. (92% inhibition) all the cells took up Trypan Blue, there was " budding"
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FIG. 9.-The percentage inhibition of the rate of oxygen uptake of mouse macrophages is
proportional to log1o [dose of lysolecithin per cell]. The 50% inhibition dose is 4-24 ,ug./106
cells.
and swelling of cells with some obvious cell membrane breaks and cell debris. At
higher lysolecithin concentrations gross coagulation was noted.
DISCUSSION
Q02 values are usually expressed in terms Of 02 taken up/mg. dry wt/hr; but
as Leslie, Fulton and Sinclair (1957) have pointed out, " it would seem more
logical to put results on a per cell basis, since discussions are always made on the
assumption that one cell type is being compared with another ". In the present
experiment it is the activity of the whole cell, not that of the individual enzyme
systems, which is being considered, therefore Q02 has been expressed in terms of
,tmoles O2/107 viable cells per hour. The values obtained are shown in Table I,
which also records comparable Q02 values reported by other workers using
mammalian leucocytes. We found that BP8 cells and, to a lesser extent, rat
hepatoma cells had a higher Q02 per cell than the normal cells studied, but when
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TABLE I.-Q02 ,uMoles O2/107 Viable Cells per Hour
BP8 Hepatoma
ascites ascites Polymorpho-
tumour tumour nuclear
cells cells leucocytes Lymphocytes Macrophages Reference
Mouse Rat . Mouse . Mouse Mouse
1-17±0-077 . 0-39 . 0-31±0-084 026±0- 024 . 027±0- 028 . This
n=22 . (2 expts) . n = 9 . n =6 . n = 10 paper
(0.1-0.95) . (0-14-0-44)
Mouse . Berk, Nelson
0-06-0-20 . and Pickett
(1960)
Rabbit . Harris and
0-4-0-91 . Barclay
(1955)
Rabbit . Cohn and
0-078-0-16 . Morse (1960)
Guinea-pig . Guinea-pig Staihelin,
0-23 . 0-62 . Suter and
Karnovsky
(1956)
TABLE II.-Q02 ,iMoles 02/mg. Dry Weight/hr.
Mouse Rat Mouse
BP8 hepatoma polymorpho-
ascites ascites nuclear Mouse Mouse
tumour cells leucocytes lymphocytes macrophages
Mean diameter (100 cells) . 16-15 16-78 11-14 5-60 10-42
Calculated volume y3. . 2200 2490 740 93 600
Calculated net weight of . 23 26 7-8 0-98 6-3
107 cells in mg.
Estimated dry weight mg. . 4-6 5-23 1-56 0-2 1-26
Q02/mg. dry weight . . 0-254 0-075 0-2 1-3 0-214
The Q02 of BP8 ascites tumour cells by direct measurement of dry weight was 0-26. Aisenberg
(1961) gave a Q02 of 0-31 for Ehrlich ascites cells.
Q02 was expressed as ,tmoles 02/mg. dry wt/hr, as shown in Table II, the lympho-
cyte because of its small size gave the highest value.
At low PO2'S the rate of oxygen uptake by the cells diminished, showing that
oxygen concentration became a limiting factor. The S Vmax values (the apparent
Michaelis constant for oxygen or KMi2) were of the order of 1-5 mm. Hg, but as
the system was rapidly altering these values must be regarded as qualitative only.
(Longmuir used a polarographic method to find the KmO2 of bacteria (1954) and
of liver cells (1957), and Froese (1962) found a KmO2 of 0-18 mm. Hg for Ehrlich
ascites cells.) We found that low concentrations of lysolecithin per cell con-
siderably increased the KmO2 values with little decrease in Vmax. This type of
effect is seen in competitive inhibition. It may indicate that these amounts of
lysolecithin reduce oxygen uptake by damaging the mitochondria or by switching
the metabolism from oxidative to glycolytic pathways. Coagulation was
excluded as a cause of this effect.
At higher concentrations of lysolecithin per cell, the percentage inhibition of
oxygen uptake increased and was found to be proportional to log [dose of lyso-
lecithin per cell]. The values for 50% inhibition of all the cell types studied are
listed in the first line of Table III. In terms of dose per cell rat hepatoma cells
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were the least sensitive, followed by polymorphonuclear leucocytes, BP8 cells,
lymphocytes and macrophages. Fischer's (1964) claims could therefore not be
confirmed, and his experiments have already been challenged as not truly repre-
senting the effect of lysolecithin itself on the cells.
TABLE III.-Dose of Lysolecithin ,tg./106 Total Cells and in ,tg./,u2 of Cell Surface
which Produced 50% Inhibition ofOxygen Uptake in Mouse and Rat Cells
Mouse Rat Mouse
BP8 hepatoma polymorpho-
ascites ascites nuclear Mouse Mouse
tumour cells leucocytes lymphocytes macrophages
50% inhibition dose ,ug. 6-4±0 78 11-8±0-81 8-4±0 73 4-5±0-31 4-24±0 28
lysolecithin/106 total cells
Mean area of 100 cellspu2 850
- 7+ 29 -3 906 - 8 ±31 -1392-9±7-4 102-9±4i3 352- 9+12- 7
50% inhibition dose per p2. 7 5±0 95 13-0±0-99 21-4±1-89 43-3±3-53 12-0±0-92
of cell surface
pg./p2 X 10-1
Haemolysis of erythrocytes is complete with 0 3 pg. (concensus of several references), area of
human erythrocyte is 140 p2 (Wintrobe, 1952) therefore lysolecithin 2-15 X 10-i pg./p2 gives com-
plete haemolysis of erythrocyte.
Tumour cells, however, are considerably larger than the leucocytes studied;
and since lysolecithin is a surface active agent, its activity must be expected to
depend on the surface area of the cell involved. The diameters of 100 cells of
each type were therefore measured under the phase contrast microscope in a
hanging drop suspension. These data are shown in Table II, and the means and
S.E.M. of the 100 areas calculated from the diameters are shown in Table III.
The 50% inhibition dose in ,ug. per square micron of cell surface was calculated,
and on this basis the BP8 tumour cell was found to be most sensitive and the
lymphocyte least sensitive to the action oflysolecithin.
This type of analysis we believe is justified by the results of those who have
studied the effects oflysolecithin on red cells. For instance, Gorter and Hermans
(1943) found that haemolysis occurred when enough lysolecithin was present on
the surface of the cell to form a complete monolayer. Hughes (1935) gives
108 A2 for the molecular area of lysolecithin; and Klibansky and de Vries (1963)
calculated from this figure that 0.1 ,tg./106 cells would be necessary for lysis, and
showed that 0 01 /1g./106 cells, measured by direct lipid analysis, caused sphering
oferythrocytes. But they also found that only 20% ofthe lysolecithin in suspen-
sion became attached to the cell membrane, and, from the data of several other
workers, a figure of 03 /tg./106 cells emerges for haemolysis by the lysolecithin in
suspension. (Gorter and Hermans (1943), Scarinci, Parenti, Cantone and Ravaz-
zoni (1960); Hartree and Mann (1960), Phillips and Middleton (1965).) Taking
the area ofthe erythrocyte as 140#a2 (Wintrobe, 1952) gives a valueof 2 15 x 10-9
,ug. lysolecithin per It2 of cell surface for the haemolysis of erythrocytes. It will
be seen that this value is much less than the 7-5 X 10-9 tg./t2 required to produce
50% inhibition ofoxygen uptake in BP8 tumour cells (Table llI).
The effect of lysolecithin on erythrocytes is probably due to the formation of
either lysolecithin-cholesterol complexes (Collier, 1952) or lysolecithin complexes
with the lecithin ofthe cell membrane (Klibansky and de Vries, 1963). Resulting
changes in the micellar shape ofthe discs oflecithin alter the surface activity ofthe
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red cell to produce sphering. The formation of such complexes would involve
irreversible attachment of lysolecithin to the cell. The present experiments have
confirmed this irreversibility for the cells studied, by showing that inhibition was
completed rapidly and that once attached the lysolecithin was not available for
other cells. However, the effect of lysolecithin on tumour cells and leucocytes is
certainly more complex. Mouse lymphocytes, with rather less surface area than
human erythrocytes, required lysolecithin in 15 times the haemolysis dose to
produce 50% inhibition ofthe oxygen uptake. This dose caused distortion ofthe
cell surface but complete lysis did not occur even with 20 ,ug./106 cells-66 times
the dose required to produce haemolysis. It is possible that the red cell surface is
more susceptible to structural damage which then proceeds to haemolysis, whereas
a similar change in leucocytes may merely lead to increased permeability. Albu-
min is a powerful inhibitor of lysolecithin, and the white cells may be able to
slough off proteins into the lysolecithin suspension.
Such changes in cell-surface properties would not necessarily bring about a
decrease in oxygen uptake. However, intracellular actions of lysolecithin have
also been reported. Particles which carry out oxidative phosphorylation are
rich in phospholipids (Cooper and Lehninger, 1956), and low concentrations of
lysolecithin protect phospholipids from salt precipitation (Saunders, 1957).
Habermann (1954) found that lysolecithin inactivated the enzymic systems of
oxidative phosphorylation in liver homogenates, and suggested that phospho-
lipids played a role between respiration and phosphorylation. Witter, Morrison
and Shepardson (1957) found that lysolecithin acted on the binding structures of
the enzyme complex rather than on the individual enzymes: inhibition of oxi-
dative phosphorylation would be expected ifspatialdisarrangement ofthe enzymes
on the mitochondrial cristae occurred. They showed that lysolecithin uncoupled
oxidative phosphorylation, decreased the oxidation of substrates and decreased
the stability ofmitochondria. They postulated that lysolecithin in low concentra-
tion played a part in the control of normal oxidative phosphorylation. Nygaard,
Dianzani and Bahr (1954) observed disintegration of mitochondria and inactiva-
tion of succinoxidase systems. Seven minutes incubation was sufficient: 10
mg./ml. caused complete destruction of the suspension used, while 041 mg./ml.
caused less than 10% destruction. Witter and Cottone (1956) observed swelling
of isolated mitochondria with lysolecithin. Finally Hartree and Mann (1960)
found that lysolecithin caused stimulation ofoxygen consumption by ram sperma-
tozoa at concentration less than 1 mm, but inhibition at concentrations greater
than this.
In terms of the whole cell, therefore, it may be suggested that lysolecithin has
two actions. The first is to increase the permeability of the membrane. This
would allow entry of lysolecithin into the cell in sufficient concentrations to
disorganize mitochondria and inhibit oxidative phosphorylation. If this were so,
it would be suspected that there would be a minimum of lysolecithin needed per
cell before any inhibition occurred. This was in fact observed; at concentrations
less than 1 flg./106 cells, no inhibition occurred. (A similar minimum was ob-
served for BP8 cells and lymphocytes: it was the slope ofthe inhibition curve that
varied.) The stimulation of oxygen uptake observed in lymphocytes at low
lysolecithin concentrations might be explained by entry ofvery small amounts into
the cell, stabilizing the mitochondria according to the suggestion put forward by
Saunders (1957).
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With respect to a possibly greater action of lysolecithin on tumour cells than
on normal cells, two observations are important. Ponder and Ponder (1964)
found that extracts oftumour cells had a greater haemolytic activity than extracts
oflung or liver. They postulated the existence oflysolecithin inhibitor, which was
more strongly bound in normal tissues. Furthermore, Gray (1963) found that
although there was no great increase of lysolecithin in Landschutz and BP8
ascites tumours, the membrane lipids had a less specific organization offatty acids
and a rather high proportion of breakdown products. He suggested that " the
presence of substantial amounts of monoglyceride, phosphatidic acid and lysole-
cithin may reflect a tendency to general breakdown of tumour lipids, perhaps by
enzymes released by changes in membrane permeability ". Both explanations
would account for an increased sensitivity to lysolecithin.
In conclusion, care must be taken in extrapolating these results to conditions
in solid tumours in vivo. Unknown factors e.g. the amount of lysin-inhibitors
such as albumin in the extracellular fluid, and the abilityoflysolecithin micelles to
diffuse through the extracellular space-must be taken into account. Further-
more, the effect of lysolecithin on tumour capillaries, and the possibilities of
haemorrhage or increased vascular permeability (Cater and Taylor, 1966) may
complicate the issue. The present results, however, have suggested that further
work along such lines might be rewarding.
SUMMARY
1. A method is described for measuring the oxygen uptake of cell suspensions
in vitro, by means of Silver's oxygen cathode.
2. BP8 ascites and rat hepatoma cells had a higher respiratory rate on a per
cell basis than polymorphonuclear leucocytes, lymphocytes, or macrophages.
3. Lysolecithin inhibited the oxygen uptake of all cell types studied, at
concentrations greater than 1.0/ag./106 cells. The degree of inhibition was
proportional to the logarithm of the dose of lysolicithin per cell. In terms of
surface area, tumour cells were more sensitive than lymphocytes or polymorpho-
nuclear leucocytes.
4. Concentrations of lysolecithin less than 1 ,ug./106 cells caused no inhibition
of oxygen uptake. In two experiments, such concentrations stimulated the
oxygen uptake oflymphocytes.
5. Low concentrations of lysolecithin caused an increase in the apparent
KmO2 value for the cells.
6. Lysolecithin-treated cells characteristically showed increased permeability
to Trypan Blue, distortion ofthe cell membrane, and often coagulation.
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